Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 1/20 | 0.51 |
| ▸ | ACACB | O00763 | 15/20 | 0.49 |
| ▸ | THRB | P10828 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5702014 | 0.91 | ELANE (0.60) | ELANEACACBTHRBALDH1A1PLA2G1B | |
| SCHEMBL4064862 | 0.84 | ACACB (0.60) | ELANEACACB | |
| SCHEMBL13845227 | 0.84 | ELANE (0.74) | ELANETHRBALDH1A1PLA2G1BKMT2A | |
| SCHEMBL4055000 | 0.83 | ELANE (0.59) | ELANETHRBALDH1A1PLA2G1BKMT2A | |
| SCHEMBL4055926 | 0.83 | ELANE (0.59) | ELANETHRBALDH1A1PLA2G1BKMT2A | |
| SCHEMBL13845209 | 0.82 | ELANE (0.50) | ELANEACACBTHRBALDH1A1PLA2G1B | |
| SCHEMBL16726556 | 0.81 | THRB (0.60) | ELANETHRBALDH1A1KMT2A | |
| SCHEMBL4057131 | 0.81 | ELANE (0.49) | ELANEACACBTHRBALDH1A1PLA2G1B | |
| SCHEMBL4055579 | 0.81 | THRB (0.55) | ACACBTHRBALDH1A1PLA2G1BKMT2A | |
| SCHEMBL4064336 | 0.81 | ELANE (0.58) | ELANEACACBKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7534547-B2 | Optically active compound and photosensitive resin composition | OSAKA GAS COMPANY LIMITED (JP) | 2009-05-19 | — | — | US | disclosed |
| US-7534547-B2 | Optically active compound and photosensitive resin composition | OSAKA GAS COMPANY LIMITED (JP) | 2009-05-19 | — | — | US | disclosed |
| EP-1375463-A1 | OPTICALLY ACTIVE COMPOUND AND PHOTOSENSITIVE RESIN COMPOSITION | Kansai Research Institute, Inc. (JP) | 2004-01-02 | — | — | EP | disclosed |
| US-20030211421-A1 | Optically active compound and photosensitive resin composition | KRI, INC. (JP) | 2003-11-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030211421-A1 | Optically active compound and photosensitive resin composition | ARCN1, RAD51, PAM | ELANE 422/4885ACACB 4685/4885THRB 4106/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.